MacroGenics
MGNX
#8857
Rank
$0.22 B
Marketcap
$3.60
Share price
0.14%
Change (1 day)
112.06%
Change (1 year)

Operating Margin for MacroGenics (MGNX)

Operating Margin as of October 2026 (TTM): -62.33%

According to MacroGenics's latest financial reports and stock price the company's current Operating Margin is -62.33%. At the end of 2025 the company had an Operating Margin of -44.67%.

Operating Margin history for MacroGenics from 2013 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
2025-44.67%3.21%
2024-43.28%233.35%
2023-12.98%-83.74%
2022-79.83%-70.12%
2021-267.20%99.31%
2020-134.06%-53.07%
2019-285.67%-2.15%
2018-291.94%1950.38%
2017-14.24%-79.47%
2016-69.35%241.44%
2015-20.31%-74.95%
2014-81.07%-12670.31%
20130.64%-95.31%
201213.76%23.3%
201111.16%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Pfizer
PFE
12.01%-119.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
42.17%-167.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
27.00%-143.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-6.41%-89.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
32.40%-151.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
24.21%-138.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-153.22% 145.82%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.